An automated method for the determination of deoxyribonuclease activity as exemplified by fractionation of the components of the medicament Varidase(®)

por Locke, I. C., Ramsey, M. P., Hill, S. S., Carpenter, B. G.
Publicado 1993

Melanocortin Peptide Therapy for the Treatment of Arthritic Pathologies

por Getting, S. J., Kaneva, M., Bhadresa, Y., Renshaw, D., Leoni, Giovanna, Patel, H. B., Kerrigan, M. J. P., Locke, I. C.
Publicado 2009

1748P Real-world outcomes in thoracic cancer patients (pts) with severe acute respiratory syndrome coronavirus 2 (COVID-19): Single UK institution experience

por Cui, W., Yousaf, N., Bhosle, J., Minchom, A.R., Ahmed, M., McDonald, F., Locke, I., Lee, R., O'Brien, M., Popat, S.
Publicado 2020

Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers

por Kote-Jarai, Z, Salmon, A, Mengitsu, T, Copeland, M, Ardern-Jones, A, Locke, I, Shanley, S, Summersgill, B, Lu, Y-j, Shipley, J, Eeles, R
Publicado 2006

180P Incidence of brain metastases (BM) in newly diagnosed stage IV NSCLC during COVID-19

por Cui, W., Milner-Watts, C., Saith, S., Bhosle, J., Minchom, A.R., Davidson, M., Page, S., Locke, I., Yousaf, N., Popat, S., O'Brien, M.E.R.
Publicado 2021

Urocortin protects chondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis?

por Intekhab-Alam, N Y, White, O B, Getting, S J, Petsa, A, Knight, R A, Chowdrey, H S, Townsend, P A, Lawrence, K M, Locke, I C
Publicado 2013

Chondroprotection by urocortin involves blockade of the mechanosensitive ion channel Piezo1

por Lawrence, K. M., Jones, R. C., Jackson, T. R., Baylie, R. L., Abbott, B., Bruhn-Olszewska, B., Board, T. N., Locke, I. C., Richardson, S. M., Townsend, P. A.
Publicado 2017